Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FS8QS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,777
Award facts
- Contract value 100% obligated
- $13,776.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,776.67 to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication. This non-competitive delivery order represents a firm fixed price transaction with a completion deadline of December 19, 2025, and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026 that enables the company to furnish pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant federal procurement presence as a critical vendor for Department of Defense medical supply chains. The company's extensive portfolio of federal contracts demonstrates its capability to deliver diverse pharmaceutical commodities—including specialty medications, generic drugs, vaccines, and medical devices—across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, and other federal health systems. This delivery order for TRELEGY ELLIPTA, a respiratory combination therapy, reflects the company's ongoing role as a primary pharmaceutical supplier within the DLA's medical procurement framework.
Quick answers
Who was awarded contract SPE2DR26FS8QS?
SPE2DR26FS8QS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FS8QS worth?
The government has obligated $13,777 on SPE2DR26FS8QS.
Is contract SPE2DR26FS8QS an order under another contract?
Yes. SPE2DR26FS8QS is a delivery order under SPE2DR25D3021, an indefinite delivery contract.
Was contract SPE2DR26FS8QS competed?
The extent of competition for SPE2DR26FS8QS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award